Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

New indication for AZ’s checkpoint antibody

Country: United States

AstraZeneca Plc has won a new indication for its checkpoint antibody Imfinzi (durvalumab) from the US Food and Drug Administration to reduce the risk of non-small cell lung cancer progressing. Imfinzi targets the programmed death ligand-1 (PD-L1).

Read more

Roche to acquire Flatiron Health

Country: Switzerland

Roche is to advance its strategy for delivering personalised medicines with the acquisition of Flatiron Health Inc, a company with technology for analysing real-world data from cancer patients. Roche is to pay $1.9 billion for the 87.4% of the company it doesn’t already own.

Read more

Avelumab doesn’t meet endpoint in lung cancer trial

Country: Germany

Read more

Pieris raises additional money from US IPO

Country: United States

Read more

Gates Foundation funds Novartis drug

Country: Switzerland

Read more

FDA approves cancer drug using novel endpoint

Country: United States

Read more

Pieris raises $44 million in US IPO

Country: United States

Read more

Synpromics works with UCL

Country: United Kingdom

Read more

Cognitive diseases targeted

Country: Belgium

Read more

Novo Nordisk targets obesity

Country: Denmark

Read more

ViiV Healthcare sues Gilead over patent

Country: United Kingdom

Read more

Combination has impact in kidney cancer

Country: Switzerland

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

The advance of digital medicine by Jean-Claude Muller

DigitalMedicineReviewJean-ClaudeMullerFeb2018.pdf

Highlights of the January 2018 MedNous issue

The January 2018 MedNous features:

Latest Mednous cover
  • Gene Editing
    Interview with Orchard Therapeutics
  • Commentary
    The three waves of gene therapy By Frank Schnieders
  • Research Strategy
    Building the next generation of gene transfer vectors By Michael Roberts
  • Oncology Review
    Global oncology drug approvals accelerate By Bruno Pagliara
  • Biotech Finance
    BioNTech raises $270 million for cancer vaccines
  • Regenerative Medicine
    Takeda to acquire TiGenix
  • Quarterly Stock Market Review
    Biotechs buoyed by share issues

The latest MedNous journal. Subscribe to download.